Perthera, Inc.
Precision oncology platform using artificial intelligence to guide personalized cancer treatment selection
- Sector
- Digital health
- Headquarters
- MCLEAN, VA
- Founded
- 2011
- Latest Form D
- $500K, Apr 2022
- Total capital
- $12.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $12.9M
- 6 Form D · last Apr 2022
- 55 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 7 pending · first 2018
- Rank in peer group#12 of 312
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 6th filing$500K
- Private capital raisedForm D · SEC · 5th filing$2.1M
- Private capital raisedForm D · SEC · 4th filing$750K
- Private capital raisedForm D · SEC · 3rd filing$9.2M
- Private capital raisedForm D · SEC · 2nd filing$100K
- Private capital raisedForm D · SEC · 1st filing$300K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 312 peers
Line = medianDigital health · Platform
- Granted patents#12 · top 4%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Albert T KelleyExecutive Officer, DirectorNamed in SEC Form D filings
- Andrew Dendy MignattiExecutive Officer, DirectorNamed in SEC Form D filings
- Emanuel Dendy PetricoinDirectorNamed in SEC Form D filings
- Federoff HowardDirectorNamed in SEC Form D filings
- Gary GregoryExecutive OfficerNamed in SEC Form D filings
- John Robert WalkerDirectorNamed in SEC Form D filings
Show all 10 people
- Michael Dendy YoungDirectorNamed in SEC Form D filings
- M. Dendy YoungExecutive Officer, DirectorNamed in SEC Form D filings
- Neal Dendy KollerExecutive Officer, DirectorNamed in SEC Form D filings
- Neil Dendy CallahanDirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 13- New patentMethods For Predicting Relative Benefit Of Therapy Options And Devices ThereofUSPTOUS 12,763,212
- PendingMethods For Predicting Relative Benefit Of Therapy Options And Devices ThereofUSPTOApplication 18731179
- GrantedOutcome Driven Persona-typing For Precision OncologyUSPTOUS 11,574,718
Show all 13 patent records
- Methods For Predicting Relative Benefit Of Therapy Options And Devices ThereofOct 13, 2026 · US 12,763,212Granted
- Methods For Predicting Relative Benefit Of Therapy Options And Devices ThereofDec 5, 2024 · Application 18731179Pending
- Outcome Driven Persona-typing For Precision OncologyFeb 7, 2023 · US 11,574,718Granted
- Integration Of Multi-omic Data Into A Single Scoring Model For Input Into A Treatment Recommendation RankingOct 18, 2022 · US 11,475,995Granted
- Systems And Methods For An Expert System For Precision OncologyNov 21, 2019 · Application 16475349Pending
- Display Panel or Portion Thereof With a Graphical User InterfaceJun 18, 2019 · US D,851,665Granted
- Display Panel or Portion Thereof With a Graphical User InterfaceSep 4, 2018 · US D,827,664Granted
- Display Panel or Portion Thereof With a Graphical User InterfaceAug 28, 2018 · US D,826,972Granted
- Outcome Driven Persona-typing For Precision OncologyApplication 62678896Pending
- Methods For Predicting Relative Benefit Of Therapy Options For Patients With Metastatic Pancreatic Cancer And Devices ThereofApplication 63505217Pending
- Methods For Predicting Relative Benefit Of Therapy Options And Devices ThereofApplication PCTUS2024032142Pending
- Integration Of Multi-omic Data Into A Single Scoring Model For Input Into A Treatment Recommendation RankingApplication 62667927Pending
- Systems And Methods For An Expert System For Precision OncologyApplication PCTUS2017068953Pending
Related companies, and why
- GENEIAL LLCSimilar federal contract value in Digital health · null in contracts
- BROOKSIDE RESEARCH & DEVELOPMENT COMPANYSimilar federal contract value in Digital health · null in contracts
- REMMIE, INC.Similar federal contract value in Digital health · null in contracts
- Color of the Sun, LLCSimilar federal contract value in Digital health · null in contracts
- NXTECH INCSimilar federal contract value in Digital health · null in contracts
- MOVE, LLCSimilar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .